Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by jwalliscaon Mar 24, 2020 1:32pm
155 Views
Post# 30842363

Sernova Scholarly Update: "ALL is AOK" :)

Sernova Scholarly Update: "ALL is AOK" :)
The link below gives readers the details. One has to read between the lines, but the short is Sernova is AOK. The FDA trial is AOK and continues even in this awful COVID-19 environment. In case, readers didn't know, some companies have had to go as far as to close down completely.
 
If one were to compare some of the wording with previous releases and to note the explicitness in explanations "Why is This Important?", it actually has more impact and importance than at first glance. I compared some wording of some items with past releases and the MD&A. The news today says to me that Sernova is making progress on more than just the FDA trial front. 
 
As has happened in the past, none is paying attention and the share price has weakened slightly. History repeats itself until it doesn't... witness Bellus (BLU) and Trilium (TRIL)... nothing, nada, zippo, zilch and then BOOM, BOOM.   
 
Happy and waiting for the Boom, Boom part in Cowtown, 
jwall 
Bullboard Posts